Notice is hereby given that pursuant to Regulation 25 (3 & 4) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, and Schedule IV, clause VII of the Companies Act, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics Ltd has informed BSE about a separate meeting of its Independent Directors scheduled for Wednesday, March 18, 2026, at the company's registered office in Goa. The meeting is being held as required under SEBI's Listing Regulations and Schedule IV of the Companies Act, 2013. The agenda includes reviewing the performance of Non-Independent Directors, the Board as a whole, and the Chairman, as well as assessing the quality and timeliness of information flow between management and the Board. The notice was signed by Company Secretary Pooja Bicholkar on March 9, 2026.
This is a routine corporate governance compliance filing with no material impact on shareholders or stock price. It reflects standard regulatory adherence by the company.